Title: Overpopulation and Voluntary Family Planning: Setting a New Health Political Agenda

Abstract:

Overpopulation and Voluntary Family Planning: Setting a New Health Political Agenda

Voluntary family planning allows people to attain their desired number of children and determine the spacing of pregnancies. It is achieved through use of all available contraceptive methods. Family planning is key to slowing unsustainable population growth and the resulting negative impacts on the economy, environment, and national and regional development efforts.

Contraceptive use has increased in many parts of the world, especially in Asia and Latin America, but continues to be low in sub-Saharan Africa. Nevertheless ‘Three Successful Sub-Saharan Africa Family Planning Programs’ show how African best practises of Ethiopia, Rwanda and Malawi share a common strategy: Contraceptive prevalence has risen steadily from a low starting point and moved upward sharply in most years in all three countries: from 2000 to 2011 in Ethiopia from 6.3% to 27.3%, in Rwanda from 5.7% to 45% and Malawi from 26.1% to 42.2%. Such progress is helping these countries move closer to what the development community calls “the demographic dividend”.In particular these achievements have been possible due two main strategies:

1) countries dramatically reduced financial barriers to access modern contraceptives.

2) huge task shifting, reducing physical distances from the poorest to the provision of services have been done with training schemes: provision of long-acting family planning methods shifted from doctors (therefore from hospitals) to nurses at the health centre level while provision of condom and pills shifted from nurses (health centre level) to trained community health workers, present in every single village. most recent WHO published data estimate that 214 million women of reproductive age in developing regions who want to avoid pregnancy are not using a modern contraceptive method: a huge unmet need. According to WHO and UNFPA, providing access to these women would prevent 67 million unintended pregnancies and would reduce induced abortions from 48 million to 13 million. It would also reduce maternal deaths by 76,000 per year, new-born deaths from 2.9 million to 660,000 per year and HIV infections in new-borns from 130,000 to 9,000.

Biography:

Michele Usuelli has lead and managed the neonatal emergency transport system, STEN. He is lead and managed clinical and research program of Neonatal care in developing countries for 7 years. He is a senior neonatologist at 3rd level NICU with capacity of managing up to 25 ventilated newborns, pre-post operatory management of surgical newborns, intensive/subintensive NICU and the biggest public in Italy. At present on leave. Since May 1st I have been elected in the regional assembly of Lombardy. (In Italy health is directly managed by regions).

Title: Advancement Treatment for Neonatal Development

Abstract:

Advancement Treatment for Neonatal Development

There are various risk factors to neonatal development during neonatal period at the first four weeks of a child’s life. Neonatal development in this period, it presents critical in brain-nerve system maturation, cardiovascular and pulmonary development, this time for a child face to risks at developing of different diseases:

1. Fetal Diseases, as Fetal Nutrition Disorders or Fetal Oxygen Distress;

2. Hereditary Diseases, as Kartagener Syndrome or Cystic Fibrosis;

3. Congenital Abnormal Diseases, as Digestive System Abnormalities or Cardiovascular Abnormalities;

4. Newborn Diseases, as, Persistent Fetal Circulation Syndrome, Neonatal Respiratory Distress Syndrome. And Immunology Immaturity

Neonatal development has studied, and genetic reasons are in basic role to develop diseases of Hereditary Diseases and Congenital Defect or Newborn Diseases. Environmental risk factors are also observed to neonatal development, the risks to neonatal are either from maternal or from the child self by mediated with the factors of infection, nutrition or function immaturity.

The advance treatment in neonatal is applied in life support treatment with oxygen supply, monitor observation and warm keeping assistant machine; pharmacology therapy, surfactant replacement or nitric oxide inhalation therapy and ECMO in pulmonary cardiological support therapy to clinical abnormal presentation. Medical Collaboration has role in critical care for neonatal diseases, there have Neonatal Intensive Care Unit, ambulance transfer and basic research based on national trust groups.

Biography:

Dr. Yan Wang is a doctor and scientist in Medicine Science, she has Medicine Bachelor degree(M.D) in General Medicine and Pediatrics in 1990, and she also has the Doctoral Philosophy Degree(Ph.D) in Emergency and Pulmonary Medicine in 1998 from the Fudan University Medical School in China. She has worked in postdoctoral Scholar and investigator role in the United States of America since 2000 at the University of Miami Medicine School, Jefferson Healthy System Albert Einstein Medical Center and University of Pennsylvania Medicine School. She has critical working experience at the Imperial College in London in 2014. Currently she is attending doctor, professor, author, leader and committee member at hospitals, universities, organizations and Journal Presses with appointed positions.

She has published first-authored articles on peer-reviewed journals and conference abstracts about 100 products, She has written medical books over 10 books in English versions published in the United States or the United Kingdom. Her publications reflect her contribution at Science, Medicine and special Pediatrics. As well, she has working experience at speeches, teaching-courses, textbook and news release during the past more than 25 years longer.

Currently she is in charge of ongoing scholarly project as writing medical books and being organization committee; as she is in endeavor of awarded or honored in science achievement and spiritual life, it has included in my article and theory.